haloperidol

Generic: haloperidol

Labeler: mylan institutional inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name haloperidol
Generic Name haloperidol
Labeler mylan institutional inc.
Dosage Form TABLET
Routes
ORAL
Active Ingredients

haloperidol 2 mg/1

Manufacturer
Mylan Institutional Inc.

Identifiers & Regulatory

Product NDC 51079-735
Product ID 51079-735_3dd4fea4-d455-5a4d-e063-6394a90ab14c
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA070278
Listing Expiration 2026-12-31
Marketing Start 2004-02-15

Pharmacologic Class

Established (EPC)
typical antipsychotic [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 51079735
Hyphenated Format 51079-735

Supplemental Identifiers

RxCUI
310670 310671 310672 314034 314035
UNII
J6292F8L3D
NUI
N0000180182

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name haloperidol (source: ndc)
Generic Name haloperidol (source: ndc)
Application Number ANDA070278 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 2 mg/1
source: ndc
Packaging
  • 100 BLISTER PACK in 1 CARTON (51079-735-20) / 1 TABLET in 1 BLISTER PACK (51079-735-01)
source: ndc

Packages (1)

Ingredients (1)

haloperidol (2 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3dd4fea4-d455-5a4d-e063-6394a90ab14c", "openfda": {"nui": ["N0000180182"], "unii": ["J6292F8L3D"], "rxcui": ["310670", "310671", "310672", "314034", "314035"], "spl_set_id": ["ad7d2f17-a4e8-4ebc-9baf-5983ac626782"], "pharm_class_epc": ["Typical Antipsychotic [EPC]"], "manufacturer_name": ["Mylan Institutional Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 BLISTER PACK in 1 CARTON (51079-735-20)  / 1 TABLET in 1 BLISTER PACK (51079-735-01)", "package_ndc": "51079-735-20", "marketing_start_date": "20040215"}], "brand_name": "Haloperidol", "product_id": "51079-735_3dd4fea4-d455-5a4d-e063-6394a90ab14c", "dosage_form": "TABLET", "pharm_class": ["Typical Antipsychotic [EPC]"], "product_ndc": "51079-735", "generic_name": "haloperidol", "labeler_name": "Mylan Institutional Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Haloperidol", "active_ingredients": [{"name": "HALOPERIDOL", "strength": "2 mg/1"}], "application_number": "ANDA070278", "marketing_category": "ANDA", "marketing_start_date": "20040215", "listing_expiration_date": "20261231"}